S01 NRPS - 名古屋大学jsbba/168/168_abstract.pdfkx Ð ¥þ , º Zo|aur:¤Ú®´@ I} 9A-¼Ô à...
Transcript of S01 NRPS - 名古屋大学jsbba/168/168_abstract.pdfkx Ð ¥þ , º Zo|aur:¤Ú®´@ I} 9A-¼Ô à...
-
1
S01
Non Ribosomal Peptide
Synthase NRPS NRPS A-T- C-
ATP tRNA
PM N
NVKDR NVKDGPTNRPS A-
C-
PM NDpgA Type III PKS
NVKDR NVKDGPT NRPS
38NVKDR NVKDGPT C-
PM NVKDR NVKDGPTDHFGA- NRPS 1 649
T- NRPS 2 81 C- NRPS 3 441NRPS -
C- ATP ORFATP
-
2
S02
NRPS NRPS
NRPSPoly(!-L-lysine)
25 35 , Fig. 1 streptothricin !- 1~7 Fig. 2NRPS Nature Chem. Biol., 4, 766-772, 2008;
Nature Chem. Biol., 8, 791-797, 2012 NRPS
Fig. 2 streptothricin (ST)
Fig. 1 Poly(!-L-lysine)
-
3
P01
0 2 4 6 7 HPLCDaidzin Genistin
44 4
HPLCGenistein
Daidzein Glycitein
P02
" A" A" APP "
A"
APPA"
A" SAMP8
T ThT TEM
A"1-42 ThT TEMA" 16
SAMP8 0.05% 4 ELISA A"A"
A" A"PCR A"1-42
ADAM10 BACE1 "ADAM10
in vitro A"in vivo A"1-42
-
4
P03 Chlorogenic Acid and its Metabolites as Antimicrobial Agents
!Faisal Kabir, Shigeru Katayama, Haruka Sugiyama, Soichiro Nakamura (Dept. of Bioscience and Biotechnology, Shinshu University)
Objectives Chlorogenic acid (CGA) is a natural chemical ester composing of caffeic acid and
(-)-quinic acid and it may be metabolized to active compounds, such as benzoic acid, ferulic acid, hippuric acid, etc, within the living body. Since it is well-known some of them elicited not only bacteriostatic ability but also bactericidal effects, the antimicrobial activity and mechanism of action of CGA and its metabolites against a gram-negative bacterium Escherichia coli were investigated.
Methods and Results E. coli IFO 3301 was used in this study. The susceptibility tests were performed using agar disc diffusion method and minimum inhibitory concentration (MIC) was measured by two-fold serial microdilution method. Chlorogenic acid and its metabolites exhibited specific antimicrobial activity and corresponding MIC values. Ferulic acid, isoferulic acid, benzoic acid and hydroxy benzoic acid were showed a remarkable antimicrobial effect against E. coli under thermal stress at 50ºC. E. coli cells (106/ml) completely disappeared in 2 ml of PBS coexisting with 30 mM ferulic acid and isoferulic acid incubated at 50ºC for 3 hours, followed by benzoic acid and hydroxy benzoic acid incubated at 50ºC for 6 hours. These results indicate that CGA and its metabolites possess potent antimicrobial activities against E. coli. P04
Acanthasteroside B3 ,
, . acanthasterodside B3 ,
. 1 .
Ergosterol 2 , 3
. , BF3-Et2O , OsO4 . BF3-Et2O ,
, 4 . OsO4, 1 .
acanthasteroside B3
2 3 4
3steps
1
4steps
-
5
P05 An antifungal compound, methyl 3-O-methylgallate from Tunisian halophyte, Tamarix aphylla
Asma Ben Hmidene1, Zine Mighri2 and Mitsuru Hirota1 (1 Faculty of Agriculture, Shinshu University, 2Faculty of science, University of Monastir, Tunisia)
Objectives:
Synthesized antifungal agents, such as o-phenylphenol (OPP) and ethyl p-hydroxybenzoate are used as food and/or cosmetic preservatives. The use of these chemicals are nowadays raising concerns related to food contamination and toxicity towards human. Thus, the search for less toxic antifungal agents is still required. In this study, we tried to search new antifungal compounds from some medicinal halophytes grown in Tunisia. Methods and results:
Among some Tunisian halophytes, the methanol extract of Tamarix aphylla twigs showed remarked antifungal activity against Fusarium oxysporium and Aspergillus awamori. Bioassay guided isolation led to the purification of active compound, methyl 3-O-methylgallate (M3MG). Several related compounds, including M3MG, were synthesized and subjected to antifungal assay. Their MIC values were determined based on percent radial growth. Between the synthesized compounds, M3MG showed the strongest activity. Its effect (MIC 12 mM) was even stronger than OPP (MIC 18 mM) and ethyl p-hydroxybenzoate (MIC19 mM) in the case of Fusarium. The structure activity relationship study revealed that methylation of meta-hydroxyl group in methyl gallate is a factor of antifungal efficiency enhancement. P06
Effects of gambir (Uncaria Gambir Roxb.) extract in a mouse model of allergic asthma !Pramita Sari Anungputri1,2 Nami Nakagawa1 Masahiro Nishio1, Hayato Umekawa1 (1Grad. School of
Bioresources, Mie Univ., 2Fac. of Agriculture, Sriwijaya Univ., Indonesia)
Introduction Allergic asthma is a respiratory inflammatory disease, characterized by reversible obstruction and hyper-responsiveness in airway. Th2 cytokines, such as IL4, stimulate production of allergen-specific IgE and may play important role in the pathophysiology of asthma. Gambier, Indonesian traditional food, has been reported to contain high amount of catechin. In this study, we examined the effect of gambir extract on mouse model of asthma induced by ovalbumin (OVA).
Methods and Results The mice (ddY, male, 7 week) were sensitized using OVA and alum in subcutaneous injection for 3 times every 7th day. Then the mice were immunized by gambir extract using nebulizer for 5 days, followed by exposure to OVA for 5 days. Pathological study of lung tissues was performed by HE-stain. The leukocyte count and the IL4 production were measured in both blood and bronchoalveolar lavage fluid (BALF). HE-stain showed that gambir extract-treated mice significantly reduced the airway smooth muscle thickness. Moreover, gambir extract had a tendency to reduce the levels of leukocyte and IL-4 both in blood and BALF. These observations suggest that gambir extract reduced airway inflammation of the lung tissue in a mouse model of allergic asthma. Keywords: gambir extract, catechin, asthma
OCH3
O
H3CO
HO
HO
-
6
P07 ABCG2
ABC ABCG2 ABC ABCB1ABC
1 ABCABCB1 ABCG2
ABCG2
Flp-In System (Invitrogen ) 12 FRT ABCB1ABCG2 ABCG2 (Tamura et al., J. Exp.
Ther. Oncol., 6, 1-11, 2006.) 5 # 103 cells/well 96 well plate 2472 MTT 3 20% SDS
. CO2 630 nm570 nm ABCB1
ABCG2ABCG2 3 1 ABCG2 Q141K
ABCG2
P08
ABC ABCB1 (
) ABCB1Calcein assay ATPase assay
(807 g)
epimagnolin (5.05 g) fargesin (3.27 g)sesamin sesamin
Calcein assay ABCB1 Calcein-AMcalcein ATPase assay ABCB1
ATP ABCB1 ATP37 epimagnolin calcein
ATP epimagnolin ABCB1
-
7
P09 destruxin E
M.anisopliae destruxinEED50 = 4.8 nM (Nakagawa et al., Bone, 33, 443-455, 2003.) destruxin E
(Yoshida et al., Org. Lett., 12, 3792-3795, 2010.)destruxin E destruxin E
destruxin E
Slc:ddY 100 ng/ml GST-RANKL 1 µg/ml M-CSF 1 ng/ml TGF-!1 100-mm diameter type I collagen-coated culture dish 72
3 # 104 cells/well half area 96 well plate 100 ng/ml GST-RANKL 1 µg/ml M-CSF 1 ng/ml TGF-!1 24
destruxin E 100 ng/ml GST-RANKL1 µg/ml M-CSF 24
destruxin EN- N- N-
N- "-destruxin E
P10
" 1 1, 2 1 1 2( )
(Wasabia japonica Matsumura)
MS NMR9 2 2 1
6 2FRAP assay
Trolox Trolox 2all-trans-lutein
-
8
P11 Pterogyne nitens nitensidine A ABCB1
1 1 1 2 Luis Octavio Regasini3 Vanderlan da Silva Bolzani3
Gert Fricker4 1 Thomas Efferth5 1 2 CLST 3 4 5
Pterogyne nitens nitensidine A
[1] nitensidine AABC ABCB1 nitensidine A
[2]
T CCRF-CEM CCRF-CEMdoxorubicin ABCB1 CEM/ADR5000 MTT assay Calcein asay ATPase assay ABCB1 nitensidine A MTT assay
CCRF-CEM CEM/ADR5000 nitensidine AABCB1 verapamil
Calcein assay CEM/ADR5000 nitensidine A Calcein-AMcalcein verapamil
nitensidine A calceinATPase assay CEM/ADR5000 ABCB1 nitensidine AATP ABCB1 ATP 37
ATP nitensidine A Hanes-Woolf Vmax = 125 µMKm = 6.4 µM Autodock4 ABCB1 nitensidine A
verapamil nitensidine A verapamil
nitensidine A ABCB1ABCB1 nitensidine A
1 Tajima et al., Cytotechnology, in press. 2 Tajima et al., Phytomedicine, in press. P12
( )
staphylococcal enterotoxin A (SEA) SEA
~6SEA : ( : 0.1~3.0 mM)
Staphylococcus aureus C-29 ( : 103~104 CFU/mL) 37 °C 24 SEASEA : SEA (5 µg/mL) ( : 0.5 3.0 mM)
37 °C 24 SEA 3~6SEA -SEA 2
6SEA SEA
SEA
-
9
P13
Retinol dehydrogenase 8 RDH8all-trans-retinal atRAL all-trans-retinol atROL RDH8
atRAL atROL RDH8 atRALatRAL atROL
RDH8 RDH8
RDH8RDH8
NIH3T3 RDH8Delphinidin-3-glucoside Cyanidin-3-glucoside Pelargonidin-3-glucoside 3Epigallocatechin gallate Epicatechin gallate 2 RDH8
atROLRDH8
B OH atROLRDH8
P14
Mentha arvensis
Agrobacterium metallothionein MTL1 M arvensis Ma-B Ma-C
Ma-B Ma-CM arvensis
M arvensis Ma-B Ma-C 0 1,000 mg/L
26 16500 700 6 M 0.1 M 200 400
Ma-B , Ma-C
M arvensis
-
10
P15
B1, B2, B3, B4 C2
B3, C2 B1,
B2, B4 phloroglucinol methyl 3,4,5-trihydroxybenzoate
B1 Yb(OTf)3 66% B2 AgBF476% B4 Yb(OTf)3 78% 2
B1 (3), B2 (4), B4 (5) epigallocatechin gallate (EGCG)
3 EGCG
P16
5 1
Helianthus tuberosus
10 70% 3min 12,000 rpm
Cry j 1 Balb/c 540 IgE
HPLC A~E Balb/c Cry j 1 3 IL-4 B IL-4
THP-1 A~E Cry j 1 3 MHC classHLA-DR
BHLA-DRB EI-MS NMR
1-(3’,4’-dihydroxycinnamoyl)cyclopentane-2,3-diol 1. 1
-
11
P17 Procyanidin B2,B3-gallate
a, a, b, b, b, c, d, b, a ( a,
b c, d )
Procyanidingallate DNA
Yb(OTf)3 gallate procyanidin B2-3-O-gallate, 3’’-O-gallate 3,3’’-di-O-gallate procyanidin B3-3-O-gallate, 3’’-O-gallate3,3’’-di-O-gallate gallate
(+)-Catechin ($)-epicatechin
Yb(OTf)3
Pd/C
gallate
EGCG prodelphinidin B31)
1) Suda, M., Katoh, M., Toda, K., Matsumoto, K., Kawaguchi, K., Kawahara, S., Hattori, Y., Hujii, H.,
Makabe, H. Bioorg. Med. Chem. Lett. 2013, 23, 4935-4939. P18
Yb(OTf)3O
OBn
OBn
OBn
OEE
BnO
OR1
O
OBn
OBn
OBnBnO
OR2
H2, Pd/C
Yb(OTf)3O
OBn
OBn
OBn
OEE
BnO
OR1
O
OBn
OBn
OBnBnO
OR2
H2, Pd/C
求核剤
求核剤
O
OR1OBn
OBn
OBnBnO
BnO O
OBn
OBn
OBn
OR2
O
OR1OBn
OBn
OBnBnO
BnO O
OBn
OBn
OBn
OR2
O
OR1OH
OH
OHHO
HO O
OH
OH
OH
OR2
O
OR1OH
OH
OHHO
HO O
OH
OH
OH
OR2
+
求電子剤
53% (R1 = G, R2 = H)22% (R1 = H, R2 = G)43% (R1 = G, R2 = G)
PCB2-3-O-gallate : quant. (R1 = G, R2 = H)PCB2-3''-O-gallate : quant. (R1 = H, R2 = G)PCB2-3,3''-di-O-gallate : quant. (R1 = G, R2 = G)
+
求電子剤
68% (R1 = G, R2 = H)28% (R1 = H, R2 = G)68% (R1 = G, R2 = G)
PCB3-3-O-gallate : quant. (R1 = G, R2 = H)PCB3-3''-O-gallate : quant. (R1 = H, R2 = G)PCB3-3,3''-di-O-gallate : quant. (R1 = G, R2 = G)
-
12
P19 Cell-free Synthesis of Horseradish Peroxidase and Manganese Peroxidase
for Bead Display-based High-throughput Screening Bo ZHU, Ryoko NINOMIYA, Takaaki KOJIMA, Yugo IWASAKI, Hideo NAKANO
(Dept. Bioeng., Grad. Sch. Bioagr. Sci., Nagoya Univ.)
PurposeA cell-free protein synthesis system can produce various types of proteins directly from DNA templates such
as PCR products, and therefore attracts great attention as an alternative protein synthesis system especially for high-throughput functional screening of proteins. Here, we report on successful expression of active horseradish peroxidase (HRP) and Phanerochaete chrysosporium manganese peroxidase (MnP) in an Escherichia coli cell-free protein synthesis system for bead display-based high-throughput screening.
Methods and results The reaction conditions of cell-free protein synthesis of HRP and MnP, such as the concentrations of hemin,
calcium ions, glutathione and disulfide bond isomerase were optimized to increase the solubility and activity of the synthesized enzyme. Then, the cell-free synthesized HRP and MnP purified using the hemagglutinin tag showed similar and higher specific activity compared to the commercial wild-type enzymes, respectively, suggesting that the cell-free system can be used as a preparative method for efficient synthesis of disulfide bond-containing metalloenzymes such as HRP and MnP.
Moreover, the cell-free synthesis of HRP in hexadecane-based emulsion and its immobilization on microbeads were successful. The activity of immobilized HRP was detected by a tyramide-based fluorogenic assay using flow cytometer. A model bead library containing genes of wild-type HRP and inactive mutant was screened, and an enrichment of the wild-type gene from the library has been achieved. Thus, the bead display and fluorogenic assay are effective for high-throughput screening of HRP. P20
Clostridium josui
9 (Cel9A, Cel9B, Cel9C, Cel9D, Cel9E) Cel9A Cel9B
C. josui cel9A, cel9B, cel9C, cel9D
cel9E pET-28a BL21 (DE345-60 pH 6.0-7.0 Cel9A, Cel9B,
Cel9C Cel9E barley -D-glucan Cel9D Konjac glucomannanCel9A Cel9B Cel9A
3 1-4 2 1-4Cel9B 2 1-4
Cel9A Cel9B CBM3c CBM4Cel9A Cel9B
Cel9A Cel9B CBM
-
13
P21
Clostridium josui CBM3CBM3
Clostridium josui CipA CBM3 CBM3CBM3 CBM3
CBM3
CBM3CBM3
CBM3CBM3
P22
-
14
P23
90MPaCelluclast 1.5L
1)
Celluclast 1.5L (Novozymes) 4T ( )
3S ( ) (Avicel) 100mg 0.25M 5ml (pH4.5) 1 mg (0.1MPa) (90MPa) 506 24 RI HPLC
p- pNPG D- -1,5- b-
24Celluclast1.5L 4T 3S
pNPG "-
D- -1,5-6
Celluclast 1.5L "- 1) 2013 , 2C12p11 (2013) P24
1001
13 m 7 m 3 m25 cm
1
sFDA EB 65150 cm (25~75 cm)
90 EB 109 1010 cells/gsFDA (225 cm)
(25 cm) sFDA
-
15
P25
CO2
CMC 50℃ CMCCongoRed
PASC CMC16s rRNA Streptomyces
Bacillus Chitinophaga
P26
AspergillusManR McmA
pH PacC pHManR/McmA
A. nidulans 7pacC (pH 4.2) (pH 8.2)
qRT-PCRpacC
pacC RNA-sequencing PacC ManR
PacC ManR pacC manRPacC ManR
TLC pacCPacC ManR
-
16
P27
AA
AA AAAA
GSH GSH AAAA 1)
GSH 2) AA GSHGSH
DUG AA
DUG GSH Cys-Gly Cysdug1! dug2! dug3! AA
dug2! AA GSH Cys-Gly Dug2/3AA AA GSH
AA AA1) Cys-Gly AA 3) GSH Cys-Gly
AA 1) AMB 97: 297 (2013) 2) JBC 287: 4552 (2012) 3) Alcohol Clin Exp Res 27: 1613 (2003). P28
AA DNA
AAAA
ADH AA ALD AA
5 ADH 5 ALD ADH
AA adh2!adh3!adh4!adh5!AA Adh1p
ALD AAald6! ald6! AA ald6!
AAald6! AA
PPP ald6! AAAA Ald6p AA PPP NADPH
-
17
P29
P. methanolica MOD1
2 AOD MOD1 MOD2AOD AOD
AODP. methanolica AOD
AOD
P. methanolica AOD1% AOD
3 AODMod1p Mod2p
AOD Mod1p Mod2p
2 AOD
P30 Simple, Rapid and Simultaneous Determination of Sugar and Ethanol Contents in Fermentation Medium
!Vioni Derosya, Naoto Isono, Akira Yamaoka, Ken-ichiro Suehara, Takaharu Kameoka, Atsushi Hashimoto
(Graduate School of Bioresources, Mie University) Purpose Low utilization of sago starch (Metroxylon sagu) as food source gives a possibility to use it for
bioethanol production. Considering waste reduction, both starch and fiber of sago should be used in ethanol fermentation with glucose and xylose as the hydrolysis products. To accurately control the fermentation process, we tried to develop a simple, rapid and simultaneous determination of the sugar and ethanol contents in the medium based on the infrared spectroscopic information.
Experimental Methods & Results The fermentation media containing different concentrations of glucose, xylose and ethanol in
yeast nitrogen based (YNB) media were prepared for the infrared spectroscopic measurements. The spectra were collected using a Fourier transform infrared (FT-IR) spectrometer equipped with an attenuated total reflectance (ATR) accessory in the range from 4000 to 400 cm-1.
The strongest peaks characterizing glucose, xylose and ethanol in YNB media were observed at 1036, 1050 and 1046 cm-1, respectively. All calibration curves for each metabolite at these wavenumbers presented excellent linearities. Moreover, the intercepts of the calibration curves, which may theoretically show the absorbance of the medium without metabolite, were almost same as the experimental values. The metabolite contents in the mixture media were simultaneously calculated under the assumption that the spectral additivities could be satisfied. Consequently, the good agreements were observed between the actual and calculated values. This study could contribute the simple, rapid and simultaneous monitoring of the metabolites during bioethanol fermentation.
-
18
P31 A2
pelB Streptomyces violaceoruberA2 svPLA2
svPLA2ELISA
svPLA2 pET
Skp100 mL 0.1 mg
PLA2-scFv PLA2ELISA
P32
-
19
P33 Uniform Emulsion for Biochemical Applications Using Inexpensive Flow-Focusing Device !Marsel MURZABAEV1, Takaaki KOJIMA1, Isao KOBAYASHI2, Hideo NAKANO1
(1Dept. Bioeng., Grad. Sch. Bioagr. Sci., Nagoya Univ., 2Food Engineering Div., National Food Research Inst.)
[Purpose]
Carrying out biochemical reactions such as PCR or cell-free protein synthesis in water-in-oil emulsion allows high-throughput screening of large libraries of biomolecules, where each droplet functions as an independent reactor. But droplets generated by bulk emulsification greatly vary in size, which leads to uneven distribution of reagents and causes difficulties in statistical analyses. Microfluidic devices can generate monodisperse emulsion but are expensive and require special equipment. We are working on development of inexpensive device which can generate monodisperse emulsion from biological samples.
[Methods and results]
We could make a relatively simple flow-focusing device which can produce monodisperse emulsion. It consists of two syringes driven by syringe pumps, standard fittings and tubes and a specially fabricated nozzle. This nozzle is made of a larger glass capillary for oil phase, smaller steel needle for water phase and a thin insulin needle for emulsification connected to the exit capillary. Using this device we could produce emulsion droplets that have an average diameter of 76,4 "m with coefficient of variation of 3,7%, which can be considered as monodisperse. Average volume was 0,000235 "l or 0,235 nl, which means 100 "l sample can be partitioned into around 425 500 compartments. We used PCR buffer with magnetic beads as a water phase, so this device can be used for emulsion PCR. P34
28 kDa LP28 18 kDa LP18
LP1877 N LP18
LP18 NLP18
LP18
LP18 N N LP18
MA104N
SDS-PAGE native-PAGESDS LP native-PAGE
native-PAGE NLP18 LP18N
-
20
P35
DFAI DFAI 50
H10-2 DFAI
H10-2 16S DNADNA Arthrobacter ramosus
98.6 ArthrobacterArthrobacter sp. H10-2
DFAI [EC4.2.2.17]35
17 pH 5.5 4075 30
SDS-PAGE 39kDa P36
YAS
-
21
P37
Oryzias latipes
8
5 2
TALEN TILLING
P38
TGaseTGase 8
TGase
mRNART-PCR, Real- Time PCR, in situ hybridization
TGase1 , TGase2
RT-PCR 21 mRNAReal-Time PCR TGase1 TGase2
In situ HybridizationTGase1, TGase2 mRNA
TGase1 TGase2
-
22
P39
TGase
TGase8
TGase12 ( )
TG2
TG7
TG2 TG7
TGase
Kuramoto and Yamasaki et al. Arch. Biochem. Biophys, (2013) P40
DNA
DNA S (ori) DNA S
72DNADNA
AB.9 ( )DNA
DNADNA
DNADNA
DNA
-
23
P41
DNA AP (apurinic/apyrimidinic site)AP DNA AP
APAP
Shewanella violacea AP (SviExo)
SviExo His
DNA SviExoAP 3’ 5’
3’#5’ Exo SviExo34 250 mM NaCl pH 9 34
SviExoAP
SviExo P42
, , . , ,
. , ATP, Mg2+ . Luciola lateralis
, . , , ,
. , , .
,
(LlLuc1)LlLuc2 . , PCR
2. , in vitro in
vivo . , LlLuc2
. , LlLuc1 LlLuc2,
LlLuc1 , LlLuc2 .
-
24
P43
24 LC/ESI-TOF-MS2 L- 1
P44
Methanosarcina acetivorans
M. acetivorans
LC-MSn
GC-MS $-1
$- 1 M. acetivorans
-
25
P45
Aspergillus AmyR
A. nidulans AmyR (IM)
AmyR GFP AmyR
A. nidulans GFP-AmyR
GFP-AmyR A. nidulans SGZ5
(ZEISS LSM700 ) GFP-AmyR
Rhodamine phalloidin GFP-AmyR AmyR
D (CD) GFP-AmyR
B (MB) GFP-AmyR AmyR
P46
Coprinopsis cinerea
Coprinopsis cinerea
C. cinerea
C. cinerea Yeast Malt Glucose 3 (30 °C) 4
12 300
30 40 MALDI-TOF/TOF-MS
MASCOT100
hypothetical protein PCR mRNA
-
26
P47
2A (SEA) SEA
SEASEA
SEA Staphylococcus aureus No.29 (EMr SEA+ ) S. aureus No.77 (KMr SEA-) SEA
No.29 No.77 6 ( ) pH 6.037 °C
NaCl (7.5%) MgCl2
(100 mM) No.29No.77
SEA P48
cis-
cis- EDLF K+
Diels-Alder IMDA cis-
2- 5 1 IMDA
cis- 2IMDA EDLF
n RO
O
O
RO
O
OnIMDAreaction
OH
OH
HO
OH
OHHHO
possible structure ofInagami-Tamura's EDLF
*
1 (n = 0, 1)2
OO
OH
OAcOAc
H
H
OAcOAcAcO
OCO2MeH
correolide
-
27
P49
NGF ( )
PC12 NGFAcanthaster planci acanthasteroside B3
acanthasteroside B3 NGFacanthasteroside B3
9.6 kg ODS 4
acanthasteroside B3 (Fr. 2) silica gel2 Fr. 2-2 Fr. 2-6 Fr. 2-6 acanthasteroside B3 (70 mg)
Fr. 2-2
acanthasteroside B3 Acanthasteroside B3PC12 NGF 3 NGF
PC12 acanthasteroside B3acanthasteroside B3 NGF
P50
streptothricin ST streptolidine lactam carbamoyl
gulosamine !-lysineST
streptolidine lactamST
STorf18 streptolidine lactam carbamoyl gulosaminestreptothrisamine Nature Chem. Biol., 8, 791-797, 2012
STST %-Red recombinase in-frame
34 kbStreptomyces avermitilis SUKA17 LCMS
carbamoyl transferase orf17 decarbamoyl-N-acetyl streptothrisamine orf8 orf11 orf13
streptolidine lactam
acanthasteroside B3
-
28
P51 ABCG2
ABC ABCG2
NN ABCG2 ABCG2
ABCG2
Flp-In System (Invitrogen ) 12 FRTABCG2(WT) N ABCG2(N596Q)
ABCG2(C603G) NABCG2(N596Q/C603G)
ABCG2SN-38 Mitoxantrone ABCG2(N596Q)
ABCG2(C603G) ABCG2(N596Q/C603G) ABCG2(WT)SN-38 ABCG2 ABCG2 mRNAABCG2(N596Q) ABCG2(C603G) ABCG2(N596Q/C603G)
ABCG2(WT) 2 1 NABCG2
N ABCG2
P52
BR BRI1 BRL1 BRL3 BR
SERK1-4BR BRI1-
BL BL " BRI1& BR
A 2&,3&-diol BRI1BL " BRI1 & A 2&,3&-diol SERKs
BRI1 SERKsBL 2&,3&-diol BL-2,3-acetonide
BR BRBL-2,3-acetonide BRI1 SERKs
BRI1 2 3BRI1BL BL HBL
2-O-alkyl-HBL 3-O-alkyl-HBL2-O-alkyl-HBL BL
-
29
P53
2C(PP2C) PPM Ser/Thr
PP2C(RANKL)
PP2C glabridin RANKLMAPK NFATc1
glabridinRANKL/RANK glabridin
RAW264 RANKL/RANK
glabridin RANKLNF- B glabridin glabridin I B
IKK / IKK NF- BI B NF- B
glabridin NF- B MAPKNF- B PP2C TAK1
glabridin glabridin TAK1glabridin PP2C TAK1 RANKL/RANK
P54
1)
﨑
25
hTAS2Rs G G#16gust44 HEK293T96 well FLEXstationTM
[Ca2+]iTAS2R 392) TAS2R14 [Ca2+]i
TAS2R39TAS2R39 TAS2R39
ECg TAS2R14 EGCg
1) T. Yamazaki, et al., Biosci. Biotechnol. Biochem. 77 (9) (2013), in press 2) M. Narukawa, et al., Biochem. Biophys. Res. Commun., 405, 620-625 (2011)
-
30
P55
Hydrangea macrophylla3- pH
0.3 MS 5 mg/L 2,4-24 16 (4500 lx) 3
HPLC3- 3-
( )
P56
(H+-PPase) (PPi)PPi
PPiPPi
H+-PPase fugu5 NO3- MGRL
H+-PPase PPi
PPase IPP1 fugu5
IPP1/fugu5 WT PPase PPiPPi
NH4+
NH4+
(Pi)Pi Pi
PPi PPi
-
31
P57
SAMclavata SAM
CLV3 CLV3 CCLE 13 4 7 Pro
7 CLV3 CLV3
CLE Arg N CLV3
CLV3
MALDI-TOF MS Arg N
SDS-PAGE 80 kDa
P58
(SAM) CLV3
CLV3
-4- (P4H)
P4H 11 CLV3total RNA RT-PCR
11 8 P4H
CLV3 in vitro CLV3 CLEP4H
-
32
P59
AtVHP1 GFP
VHP1-GFP
VHP1-GFPVHP1
GFPGFP (Kd = 110 µM)
Ara206Lys GFPGFP
GFP
GFP YFP
Ara206Lys P60
stomagenstomagen
stomagenstomagen
stomagen
stomagen
stomagen stomagen
stomagenstomagen
stomagen
stomagen C 45
-
33
P61
%-IIAEK Caco-2
Caco-2 in vitro
Caco-2 2mM 24
ATP-binding cassette transporter A1ABCA1 27 CYP27A1
mRNA ABCA1Caco-2 ABCA1 luciferase
-928 +107 2mM12 ABCA1
ABCA1 mRNAABCA1 -126 +107 LXR/RXR -77~-55
ABCA1CYP27A1 mRNA ABCA1
, mRNAABCA1 , CYP27A1 LXR/RXR
P62
(LDL)LDL LDL (LDLR) LDLR
Proprotein convertase subtilisin/kexin type 9 (PCSK9)LDL
Epigallocatechin gallate (EGCG) HepG2LDLR mRNA (Br. J. Nutr. 107, 769-773 (2012))
EGCG LDLR mRNA PCSK9 Annexin A2 PCSK9EGCG HepG2 .
HepG2 JNK ERK p38 EGCG 24 LDLR mRNA
EGCG ERK EGCGAnnexin A2 24 LDLR mRNA EGCG
PCSK9 mRNA EGCGPCSK9 mRNA 3 12 18 PCSK9
mRNA PCSK9 EGCG mRNAEGCG 3 EGCG
PCSK9 Annexin A2 ERK LDLR mRNALDL
-
34
P63
P64
B6 B6 B6 Hcy
Hcy B6B6
B6 Hcy
4 Wistar 6 n 7 1 kg 9 g L-MetC B6 D 0.49% 0.98%
1.97% 3.94% B6 D35 Hcy 6 n
7 C D 1.98% 3.97% 7.94%B6 0.061% B6 B6
Hcy C D D0.49 Hcy C D
D 1.98 B6Met
-
35
P65
( ) (P)RR
(P)RR C(P)RR C (
) N(P)RR
(P)RR FLAG (P)RR FLAG-h(P)RR
(293T) FLAG-h(P)RR FLAG(P)RR
FLAG-h(P)RR FLAGFLAG-h(P)RR
SDS-PAGE
FLAG-h(P)RR FLAG-h(P)RR70 k (p70)
(P)RR p70 (P)RR
p70 P66
PsAOX
Mt cMt-Ps
c Cyc1p Pichia pastorisPpCyc1p AOX1
AOX1
P. pastorisAOX1 PpCYC1
PpCYC1 CYC1Ppcyc1$
Ppcyc1$AOX
AOX1 Ppcyc1$AOX PpCyc1p
-
36
P67
5- Xul5PXul5P
-1,6- FBAFBA
P. pastoris FBA
P. pastoris FBA
Class-II FBA 2 PpFBA1PpFBA2 PpFBA1
PpFBA2FBA PpFba2p
P. pastoris FBA 2PpFba1p PpFba2p
FBA P68
Methylobacterium extorquens XoxF 1) XoxFXoxF1 REE MDH
M. extorquens AM1REE XoxF1 REE
Ca REE La Ce Pr
Nd AM1 AM1 Ca MDHmxaF La MDH xoxF1 2) !mxaF!xoxF1 !mxaF Ca
!xoxF1 REE Ca
AM1 REE MDH
1) Delmotte et al., 2009. PNAS 106: 16428, 2) Nakagawa T et al., 2012. PLoS ONE 7: e50480.
-
37
P69
AAAA AA
Aranda AATHI4 THI6 THI7 THI72 1) AA
AA
AA
AAAA thi4! thi6! thi7!
thi72! AA thi7! AAAA AA
in vitro AAAA AA
NADPH AA 2)
AA NADPH
1) Aranda A, et al. (2004) Appl Environ Microbiol, 70: 1913. 2) Matsufuji Y, et al. (2008) Yeast, 25: 825.
P70
!
3000 7SPBC16A3.08c (
16A3.08c ) 16A3.08c in vitro (G4) Ylr150w 16A3.08c G4 in
vitro 16A3.08c Ylr150w16A3.08c Ylr150w oga1!" (ortholog of
G4-associated protein) oga1!oga1!
Ylr150w TOR TOR tor1! Oga1
oga1! tor1!
-
38
P71
Ecl1Ecl1 80
Ecl1 H2O2Ecl1 H2O2
Ecl1 H2O2Ecl1
Ecl1 H2O2 Ecl1 H2O2
H2O2 ecl1+ H2O2ecl1+-mRNA H2O2 ecl1+-mRNA
H2O2 Sty1 MAPKAtf1 ecl1+ H2O2
atf1+ H2O2 ecl1+ ecl1+
Atf1 ChIP assay Atf1 ecl1+Ecl1 ctt1+H2O2 atf1+
Sty1 Atf1 Ecl1 ctt1+ Atf1Ecl1 ctt1+ P72
ecl1+, ecl2+, ecl3+
(Extender of Chronological Lifespan) Ecl1Ecl1
Ecl1
ecl1+,
ecl2+, ecl3+
Ecl1 Ecl1
Ecl1